Vous avez cherché: tromboosivastased (Estonien - Anglais)

tromboosivastased ained
antithrombotic agents

farmakoterapeutiline rühm: tromboosivastased ained, hepariini rühm.
pharmacotherapeutic group: antithrombotic agents, heparin group.

farmakoterapeutiline grupp: tromboosivastased ained, atc kood:
anticoagulant, atc code:

farmakoterapeutiline grupp: tromboosivastased ravimid, atc- kood:
pharmaco-therapeutic group: antithrombotic agent, atc code:

tromboosivastased ravimid takistavad verehüüvete (trombide) tekkimist.
antithrombotics are medicines which prevent the formation of blood clots (thrombosis).

farmakoterapeutiline grupp: teised tromboosivastased ained, atc- kood:
other antithrombotic agents, atc code:

farmakoterapeutiline grupp: tromboosivastased ained, ensüümid, atc- kood:
pharmacotherapeutic group: antithrombotic agents, enzymes, atc code:

farmakoterapeutiline grupp: tromboosivastased ravimid, atc-kood: b01ad07 toimemehhanism
pharmacotherapeutic group: antithrombotic agent, atc code: b01ad07 mechanism of action

farmakoterapeutiline rühm: teised tromboosivastased ained, atc-kood: b01af03 toimemehhanism
pharmacotherapeutic group: other antithrombotic agents, atc code: b01af03 mechanism of action

farmakoterapeutiline grupp: tromboosivastased ained, ensüümid, atc-kood: b01ad10.
pharmacotherapeutic group: antithrombotic agents, enzymes, atc code: b01ad10

farmakoterapeutiline rühm: tromboosivastased ained, otsesed trombiini inhibiitorid; atc kood: b01ae06.
pharmacotherapeutic group: antithrombotic agents, direct thrombin inhibitors, atc code: b01ae06.

zontivity sisaldab toimeainena vorapaksaari ja kuulub ravimite rühma nimega tromboosivastased ehk vereliistakute kokku kleepumise vastased ravimid.
zontivity contains an active substance called vorapaxar, and it belongs to a group of medicines called ‘anti-platelet medicines.’

Ärge võtke zontivityt, kui teid praegu ravitakse prasugreeli või tikagrelooriga (teised tromboosivastased ravimid).
do not take zontivity if you are currently being treated with prasugrel or ticagrelor (other anti-platelet agents).

nagu teised sarnased ravimid (tromboosivastased ravimid), võib xarelto põhjustada veritsusi, mis võivad olla eluohtlikud.
like other similar medicines (antithrombotic agents), xarelto may cause bleedings which may potentially be life threatening.

farmakoterapeutiline rühm: tromboosivastased ained, trombotsüütide agregatsiooni inhibiitorid, v.a hepariin, atc-kood: b01ac11
pharmacotherapeutic group: antithrombotic agents, platelet aggregation inhibitors excluding heparin, atc code: b01ac11

farmakoterapeutiline rühm: tromboosivastased ained, trombotsüütide agregatsiooni inhibiitor, v.a hepariin; atc-kood: b01ac04.
pharmacotherapeutic group: antithrombotic agents, platelet aggregation inhibitors excl. heparin, atc code: b01ac-04.

nendeks on atsetüülsalitsüülhape, p2y12 trombotsüütide inhibiitorid, muud tromboosivastased ained, fibrinolüütiline ravi ja krooniline mspva-de kasutamine (vt lõik 4.5).
these include acetylsalicylic acid (asa), p2y12 platelet inhibitors, other antithrombotic agents, fibrinolytic therapy, and chronic nonsteroidal anti-inflammatory drugs (nsaids) (see section 4.5).

palun informeerige oma arsti: • kui te kasutate või olete hiljuti kasutanud mingeid muid ravimeid, kaasa arvatud ilma retseptita ostetud ravimeid; • kui te võtate verd vedeldavaid ravimeid (antikoagulandid, nt varfariin) või verehüübimisvastased ravimid (tromboosivastased ravimid); • kui teid on varem ravitud angiox’ ile sarnaste ravimitega (näiteks lepirudiin)
• if you are taking, or have recently taken, any other medicines, including medicines obtained without a prescription. • if you are taking blood thinners (anticoagulants e.g. warfarin) or medicines to prevent blood clots (antithrombotics) • if you have been treated before with medicines similar to angiox (e.g. lepirudin)